Non-cell-Autonomous Cardiomyocyte Regulation Complicates Gene Supplementation Therapy for Lmna-Associated Cardiac Defects in Mice
Yueshen Sun,Congting Guo,Zhan Chen,Junsen Lin,Luzi Yang,Yueyang Zhang,Chenyang Wu,Dongyu Zhao,Blake Jardin,William T. Pu,Mingming Zhao,Erdan Dong,Xiaomin Hu,Shuyang Zhang,Yuxuan Guo
DOI: https://doi.org/10.1016/j.jacbts.2024.06.004
IF: 9.531
2024-01-01
JACC Basic to Translational Science
Abstract:The truncating mutations of LMNA are the major causes of cardiomyopathy. Here we studied 3 mouse models that carry germline, cardiomyocyte-specific, or genetic mosaic Lmna truncating mutations. Whereas the germline mutant manifested cardiac maturation defects, cardiomyocyte-specific mutation triggered pathological hypertrophy. In genetic mosaic analysis, no morphological defects were observed. Three adeno-associated virus (AAV) vectors were applied to addback lamin-A in a ubiquitous, cardiomyocyte-specific, or cardiomyocyte-excluded manner. Strikingly, only ubiquitous and cardiomyocyte-excluded AAV vectors mitigated the cardiac defects. Therefore, Lmna regulates cardiac morphology and function via a non-cell-autonomous mechanism. Noncardiomyocytes are key targets in AAV lamin-A therapy for Lmna-associated cardiac defects.